Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2025-01-20
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adipokines in Polycystic Ovary Syndrome
NCT06793072
Pro- and Anti-inflammatory Cytokines in PCOS
NCT06793085
PCOS, Therapy and Markers of Cardiovascular Risk
NCT01798875
Changes in Serum, Follicular Fluid SREBP1c and LRG1 Levels in PCOS Patients and Correlation With Insulin Resistance
NCT06066034
Activity of Chronic Inflammation in PCOS
NCT06300593
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will measure and compare the concentrations of locally acting hormones: ghrelin, kisspeptin, and zonulin in three research groups: women with polycystic ovary syndrome (PCOS) and insulin resistance (IR), women with PCOS without IR, and women without PCOS. Measurements will be performed using immunoenzymatic methods (ELISA) and the Erba XL biochemical analyzer. Statistical calculations will be conducted using SPSS Statistics software.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with polycystic ovary syndrome (PCOS) and insulin resistance (IR)
Measurement of kisspeptin concentration
Measurement of kisspeptin concentration in fasting venous blood serum
Measurement of ghrelin concentration
Measurement of ghrelin concentration in fasting venous blood serum
Measurement of zonulin concentration
Measurement of zonulin concentration in fasting venous blood serum
Women with polycystic ovary syndrome (PCOS) without insulin resistance (IR)
Measurement of kisspeptin concentration
Measurement of kisspeptin concentration in fasting venous blood serum
Measurement of ghrelin concentration
Measurement of ghrelin concentration in fasting venous blood serum
Measurement of zonulin concentration
Measurement of zonulin concentration in fasting venous blood serum
Women without PCOS
Measurement of kisspeptin concentration
Measurement of kisspeptin concentration in fasting venous blood serum
Measurement of ghrelin concentration
Measurement of ghrelin concentration in fasting venous blood serum
Measurement of zonulin concentration
Measurement of zonulin concentration in fasting venous blood serum
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Measurement of kisspeptin concentration
Measurement of kisspeptin concentration in fasting venous blood serum
Measurement of ghrelin concentration
Measurement of ghrelin concentration in fasting venous blood serum
Measurement of zonulin concentration
Measurement of zonulin concentration in fasting venous blood serum
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* treated diabetes of any type
* diagnosed and treated metabolic diseases
* diagnosed and treated autoimmune diseases
* diagnosed and treated autoinflammatory diseases
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jagiellonian University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Iwona Magdalena Gawron
PhD, MD, Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kazimierz PityĆski, Prof., Ph.D., M.D.
Role: STUDY_CHAIR
Jagiellonian University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jagiellonian University
Krakow, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1072.6120.44.2024-3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.